A recent article aims to quantify the under-reporting of adverse events (AEs) in published medical literature, compared with unpublished sources.

Medicine safety monitoring applies to all aspects of drug development, but how much is it impacted by patient diversity and study type in clinical trials?

New collaborations are seeking better safety knowledge for pregnant and breastfeeding women.